Index
Measure ID |
Title |
eMeasure ID |
Measure Type |
NQF ID |
High Priority |
Submission Methods |
Risk Adjusted? |
Registry Measure? |
442
|
Persistence of Beta-Blocker Treatment After a Heart Attack
|
|
Process |
0071
|
|
Registry |
|
|
007
|
Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)
|
CMS145v5
|
Process |
0070
|
|
Electronic Health Record | Registry |
|
|
065
|
Appropriate Treatment for Children with Upper Respiratory Infection (URI)
|
CMS154v5
|
Process |
0069
|
|
Electronic Health Record | Registry |
|
|
204
|
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet
|
CMS164v5
|
Process |
0068
|
|
Claims | Electronic Health Record | Cms Web Interface | Registry |
|
|
006
|
Coronary Artery Disease (CAD): Antiplatelet Therapy
|
|
Process |
0067
|
|
Registry |
|
|
118
|
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)
|
|
Process |
0066
|
|
Registry |
|
|
119
|
Diabetes: Medical Attention for Nephropathy
|
CMS134v5
|
Process |
0062
|
|
Electronic Health Record | Registry |
|
|
001
|
Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)
|
CMS122v5
|
Intermediate Outcome |
0059
|
|
Claims | Cms Web Interface | Electronic Health Record | Registry |
|
|
116
|
Avoidance of Antibiotic Treatment in Adults With Acute Bronchitis
|
|
Process |
0058
|
|
Registry |
|
|
163
|
Diabetes: Foot Exam
|
CMS123v5
|
Process |
0056
|
|
Electronic Health Record |
|
|
dmComposite
|
Diabetes Mellitus (DM) Composite (All or Nothing Scoring)
|
|
Intermediate Outcome And Process |
0055 & 0059
|
|
Cms Web Interface |
|
|
117
|
Diabetes: Eye Exam
|
CMS131v5
|
Process |
0055
|
|
Claims | Cms Web Interface | Electronic Health Record | Registry |
|
|
Page 10 of 75